1) Efficacy and effect
1. Primary and secondary carnitine deficiency
2. Myocardial metabolic disorders caused by ischemic heart disease: angina pectoris, acute myocardial infarction
3. Treatment of carnitine deficiency in patients with end-stage renal disease undergoing hemodialysis
2) Dosage and usage
1. Primary and secondary carnitine deficiency
Myocardial metabolic disorders caused by ischemic heart disease: angina pectoris, acute myocardial infarction
Adults: As L-carnitine, take 2-3 grams per day, divided into 2-3 doses and inject intramuscularly or intravenously.
Increase or decrease appropriately depending on age and symptoms.
2. Treatment of carnitine deficiency in patients with end-stage renal disease on hemodialysis
Initially, 10 to 20 milligrams/kilogram is administered intravenously over 2 to 3 minutes at the end of each hemodialysis session.
However, the dose can be adjusted depending on the plasma L-carnitine level before hemodialysis.
3) Packaging unit
1 ampoule (5mL) x 10
4) Ingredients, content
L-carnitine 0.2g (additives: hydrochloric acid, water for injection)
5) Period of use
36 months from date of manufacture
6) How to save
Light-proof sealed container, stored at room temperature
